Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma.
Blood Adv
; 7(6): 1056-1064, 2023 03 28.
Article
in En
| MEDLINE
| ID: mdl-36018226
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Myeloma
Limits:
Aged
/
Humans
Language:
En
Journal:
Blood Adv
Year:
2023
Document type:
Article